a Special Anniversary Rate for tct 2018!
For practicing physicians, academic researchers, and allied health professionals
For practicing physicians, academic researchers, and allied health professionals
To submit an interview request for one of these experts, please contact:
Martin B. Leon, MD, is a Professor of Medicine at Columbia University Medical Center and Director of the Center for Interventional Vascular Therapy (CIVT) at NewYork-Presbyterian Hospital/Columbia University Medical Center. Previously, Dr. Leon was also the Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian Hospital/Columbia University Medical Center and currently he serves on the Executive Board of the NewYork-Presbyterian/Columbia Heart Valve Center. Dr. Leon is the Founder and Chairman Emeritus of the Cardiovascular Research Foundation (CRF) in New York City and is currently CRF’s Co-Director, Medical Research and Education.
A distinguished pioneer in interventional cardiovascular medicine, Dr. Leon has been the national principal investigator for over 50 clinical trials that have helped shape the field including STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis. He has co-authored almost 2,000 peer reviewed scientific publications and abstracts, which have appeared in the most prestigious medical journals. As a practicing interventional cardiologist, Dr. Leon has performed over 10,000 procedures during his career.
He is the Founder and Director of Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier scientific symposium dedicated to interventional cardiovascular medicine, celebrating its 30th anniversary in 2018. He has also been the Director or Co-Director of more than 100 international educational programs in the field. Dr. Leon has received 20 international career achievement awards and was awarded an honorary degree from the University of Athens.
Dr. Leon was previously the Director of Cardiovascular Research and Education at the Lenox Hill Heart and Vascular Institute in New York as well as Director of Clinical Research at the Washington Cardiology Center at the Washington Hospital Center and Clinical Professor of Medicine at Georgetown University Medical Center in Washington, DC. He also served as a Clinical Associate, Senior Investigator, and Director of the Catheterization Laboratories in the Cardiology Branch of the National Heart, Lung and Blood Institute at the National Institutes of Health in Bethesda, Maryland. He was a founder of the Washington Cardiology Center and the Cardiology Research Foundation in Washington, DC.
Dr. Leon received his medical degree from the Yale School of Medicine and completed his internal medicine internship and residency as well as a cardiology fellowship at the Yale-New Haven Hospital.
Gregg W. Stone, MD, is Professor of Medicine at the Columbia University Medical Center, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at New York-Presbyterian Hospital, and Co-Director of Medical Research and Education at the Cardiovascular Research Foundation in New York, NY.
Dr. Stone has served as the national or international principal investigator for approximately 100 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2,000 manuscripts and abstracts published in peer-reviewed literature as well as numerous book chapters, and has delivered thousands of invited lectures around the world.
Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter mitral valve repair and replacement; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; new device angioplasty including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; left atrial appendage closure; contrast nephropathy; clinical trial design; and regulatory issues.
Dr. Stone, along with Dr. Martin B. Leon, is the director of Transcatheter Cardiovascular Therapeutics (TCT), the world's largest symposium devoted to interventional cardiology and vascular medicine, founded the annual National Interventional Cardiology Fellow's Course, and co-directs multiple other courses, including Optimizing Complex PCI Outcomes, The Chronic Total Occlusion Summit, The Left Main Summit, Bioresorbable Scaffolds: A Breakthrough PCI Technology, LAA Occlusion: A Technique Oriented Course, and Transcatheter Valve Therapies (TVT). Dr. Stone is also a director or co-director of numerous annual international courses including CIT (China Interventional Therapeutics in Beijing, China), TCTAP (TCT Asia Pacific in Seoul, S. Korea), JIM (Joint Interventional Course in Italy), and TCT Russia (in Moscow).
Dr. Stone's medical practice is devoted to Interventional Cardiology at New York-Presbyterian Hospital and Columbia University Medical Center.
Dr. Stone previously held similar positions at Lenox Hill Hospital in New York and the Washington Hospital Center in Washington, DC. Previously he was the Director of Interventional Cardiology at the Cardiovascular Institute at El Camino Hospital and Stanford University Medical Center in California.
Dr. Stone completed medical school at Johns Hopkins University Medical Center, in Baltimore, MD, and his internship and residency at the New York Hospital-Cornell Medical Center in New York City. He completed his general cardiology fellowship at Cedars-Sinai Medical Center in Los Angeles, CA, under Dr. Jeremy Swan, and subsequently a dedicated fellowship in advanced coronary angioplasty with Dr. Geoffrey O. Hartzler in Kansas City, MO.
Ori Ben-Yehuda, MD, is Executive Director of the CRF Clinical Trials Center (CTC). As Executive Director, Dr. Ben-Yehuda is responsible for all CTC activities, including trial design, data management, biostatistical analyses, event adjudication, and safety reporting. In addition, he oversees the CTC’s imaging core laboratories.
Dr. Ben-Yehuda was previously Vice President, Cardiovascular Clinical Research at Gilead Sciences. Prior to that, he was Professor of Clinical Medicine at the University of California, San Diego (UCSD) and the Director of the Coronary Care Unit at UCSD Medical Center. He also served as the Deputy Editor of the Journal of the American College of Cardiology from 2002 through 2010.
Dr. Ben-Yehuda received his medical degree from the Sackler School of Medicine at Tel Aviv University in Israel. He completed residencies in internal medicine at the Soroka Medical Center in Beer-Sheba, Israel, and New York University Medical Center and Bellevue Hospital in New York. He also finished a cardiovascular medicine fellowship at the University of California, San Diego.
George D. Dangas, MD, PhD, is Director of Academic Affairs at the Cardiovascular Research Foundation and Co-Director of Transcatheter Cardiovascular Therapeutics (TCT). He is also Professor of Medicine at the Mount Sinai School of Medicine and Director of Cardiovascular Innovation at the Zena and Michael A. Wiener Cardiovascular Institute of the Mount Sinai Medical Center in New York.
Dr. Dangas currently serves as Chair of the American College of Cardiology (ACC) Interventional Scientific Council and has been a Trustee of the Society for Cardiovascular Angiography and Interventions (SCAI). He is a key faculty and program committee member for multiple international conferences including the ACC/i2 Summit, AHA, ACCIS, JIM, and SCAI. He also recently joined the Board of Trustees of the ACC.
Before joining the faculty of Mount Sinai, Dr. Dangas was Associate Professor and Program Director of Interventional Cardiology at Columbia University Medical Center in New York and Associate Clinical Professor at New York University School of Medicine and Lenox Hill Hospital.
Dr. Dangas completed medical and postgraduate studies at the National Kapodistrian University of Athens, Greece. He finished his internship and residency in internal medicine at Miriam Hospital and Brown University in Providence, Rhode Island. He also fulfilled cardiovascular disease and interventional cardiology fellowships at Mount Sinai Hospital.
Juan F. Granada, MD, is the President and Chief Executive Officer of the Cardiovascular Research Foundation and Co-Director of Transcatheter Cardiovascular Therapeutics (TCT). A renowned leader in cardiology, he joined CRF in 2007 and served as Executive Director and Chief Innovation Officer at the CRF Skirball Center for Innovation, the preclinical division of CRF. He is also an Assistant Professor of Medicine at Columbia University College of Physicians and Surgeons.
Dr. Granada is one of the world’s foremost investigators in the in the translational validation of novel cardiovascular therapies and has helped develop and successfully validate several endovascular imaging and device technologies. Dr. Granada received his medical degree from the Institute of Health Sciences in Medellin, Colombia, and finished his internship and residency in internal medicine at the Marshfield Clinic in Wisconsin where he also served as chief medical resident. He completed his cardiovascular disease and interventional cardiology fellowships at Baylor College of Medicine in Houston, Texas.
Ajay J. Kirtane, MD, SM, is Associate Professor of Medicine at Columbia University Medical Center and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian Hospital/Columbia University Medical Center. Dr. Kirtane is a practicing cardiologist with an interest in coronary and peripheral intervention and assumed the directorship of the NYPH/CUMC cardiac catheterization laboratories in 2015. In addition to his clinical commitments at CUMC, Dr. Kirtane has a strong interest in clinical education and research, serving as Chief Academic Officer of the Center for Interventional Vascular Therapy and Director of the Interventional Cardiology Fellowship Training Program.
On the national and international level, he is a co-director of CRF’s Transcatheter Cardiovascular Therapeutics meeting, has served as a director of several international, national, and regional educational meetings, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Dr. Kirtane’s research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in interventional cardiology. He has authored or co-authored more than 150 original manuscripts and over 50 reviews and chapters including the “Coronary Stenting” chapters of the two most widely used textbooks in interventional cardiology. He has been principal investigator for several multicenter trials of interventional devices and serves on the steering committees of several large-scale clinical trials in interventional cardiovascular medicine.
Dr. Kirtane is a graduate of Princeton University and Columbia University College of Physicians and Surgeons, and completed his residency/chief residency in internal medicine at the University of California, San Francisco. He completed fellowships in cardiovascular disease and coronary and peripheral vascular intervention at Beth Israel Deaconess Medical Center/Harvard Medical School and has a Master’s of Science in Clinical Epidemiology from the Harvard School of Public Health.
Roxana Mehran, MD, is Co-Director of Transcatheter Cardiovascular Therapeutics (TCT). She is also Professor of Medicine at Mount Sinai School of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Wiener Cardiovascular Institute.
Dr. Mehran is internationally renowned for her work as a clinical trial specialist with complex data analyses and outcomes research within the field of interventional cardiovascular medicine. She currently serves on the board of trustees of the Society for Cardiovascular Angiography and Interventions (SCAI) and is a member of the Program Committee for the American Heart Association Scientific Sessions. She is also the co-founder and Program Chair of SCAI's Women in Innovations (WIN), a global initiative aimed at creating and strengthening research, educational, and professional opportunities for female interventional cardiologists.
Dr. Mehran was previously Associate Professor of Medicine and Director of Outcomes Research and Data Coordination and Analysis at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. She completed her training in internal medicine at the University of Connecticut, where she was chief medical resident before continuing her studies in cardiovascular diseases and interventional cardiology at Mount Sinai Medical Center in New York.
Gary S. Mintz, MD, is Chief Medical Officer of the Cardiovascular Research Foundation, Editor-in-Chief of TCTMD, and Managing Co-Director of Transcatheter Cardiovascular Therapeutics (TCT).
Dr. Mintz joined the Cardiovascular Research Foundation in 1991. He is the author of more than 900 articles or book chapters and 700 abstracts focusing on intravascular imaging, but also including various aspects of hemodynamics, intravascular physiology, cardiac radiology, coronary arteriography, interventional cardiology, clinical cardiology, and cardiac ultrasound. In 2005, Dr. Mintz published the single-authored textbook Intracoronary Ultrasound. In 2014, he received the “Master of the Masters” career achievement award in Seoul, Korea. In 2015, he received the Chien Foundation Award for Outstanding Lectureship and Lifetime Achievement in PCI at the TCTAP-Cardiovascular Summit in Seoul, Korea. He also serves as co-director of both the annual TCT-AP Cardiovascular Summit and the annual China Interventional Therapeutics in Partnership with TCT.
Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty (with a joint appointment in the Department of Diagnostic Radiology) in 1978 and was ultimately promoted to Professor of Medicine in 1987. His administrative appointments there included Director of the Cardiac Ultrasound Laboratory, Director of the Coronary Care Unit, and Director of the Cardiology Fellowship Training Program. He received teaching awards from both the Department of Medicine Residency and Cardiology Fellowship Training Programs.